Each week I like to look at the upcoming IPOs which are happening on the ASX. It gives me a chance to see if there are any future stars being listed and perhaps get in early on that success story. Every single share that currently trades on the ASX was a newly-listed share at one point, they should not be avoided just because they are new. A new float is usually when a private company is looking to sell a small or large portion of the business to new investors. The funds are typically needed for the growth of the…
You can continue reading this story now by entering your email below
Each week I like to look at the upcoming IPOs which are happening on the ASX. It gives me a chance to see if there are any future stars being listed and perhaps get in early on that success story.
Every single share that currently trades on the ASX was a newly-listed share at one point, they should not be avoided just because they are new.
A new float is usually when a private company is looking to sell a small or large portion of the business to new investors. The funds are typically needed for the growth of the business, such as buying property, funding product development or making an acquisition.
If any of the below shares sound interesting, you should read the prospectus to see if you want to invest.
According to ASX Ltd (ASX: ASX) these are some of the upcoming listings:
AXS Group Limited (ASX: AXS)
Its principal activity is being an integrated software solution provider to the finance, insurance and funds sector.
The software is used to originate and service any asset class until the end of its use. Its clients have entered over $100 billion in assets and in transactions onto the software platform. It aims to save time, reduce labour & workflows and lower costs for organisations.
It’s looking to raise $7 million at $0.25 per share and start trading on 28 November 2018.
EMvision Medical Devices Limited (ASX: EMV)
Its principal activity is the development and commercialisation of medical imaging technology.
The company’s technology is used to create images of the brain and other organs. EMvision says the technology is non-invasive, safe and cost-effective. Its initial focus is neurological conditions, specifically stroke care. The CEO, Dr Ron Weinberger, used to be the CEO of Nanosonics Ltd (ASX: NAN).
EMvision is looking to raise $6 million at $0.25 per share and start trading on 30 November 2018.
Qualitas Real Estate Income Fund (ASX: QRI)
Its principal activity is as a listed investment trust (LIT) investing in secured real estate loans in Australia and New Zealand.
The LIT will try to provide monthly income and capital preservation by investing in a portfolio of investments that offers exposure to real estate loans secured by first and second mortgages, mostly located in Australia. It’s targeting an 8% return per annum after fees and expenses.
It’s looking to raise $500 million at $1 per share and then list on 27 November 2018.
Redcape Hotel Group (ASX: RDC)
Its principal activity is owning and operating pubs & hotel in Australia.
It owns 29 venues, along with 21 bottle shops, three accommodation venues and The Australian Brewery.
Redcape is looking to raise $60 million at $1.13 per share and list on 30 November 2018.
It’s an interesting group of shares listing this week. EMvision could be one to watch, but it’s far too early for me to invest. Redcape and the Qualitas LIT could both generate decent returns, but they’re not in the sectors I like to invest in, so I’m happy just to watch from the sidelines.
The sectors I do like to invest include ones like these growing, defensive shares – that’s why two of them are already in my portfolio.
With interest rates likely to stay at rock bottom for months (or YEARS) to come, income-minded investors have nowhere to turn... except dividend shares. That’s why The Motley Fool’s top analysts have just prepared a brand-new report, laying out their top 3 dividend bets for 2019.
Hint: These are 3 shares you’ve probably never come across before.
They’re not the banks. Not Woolies or Wesfarmers or any of the “usual suspects.”
We think these 3 shares offer solid growth prospects over the next 12 months. The first two currently offer fat, fully franked yields. The last is a surprising REIT offering you the benefits of being a landlord with none of the hassle! You’ll discover all three names and codes in "The Motley Fool’s Top 3 Dividend Shares for 2019."
Even better, your copy is free when you click the link below. Fair warning: This report is brand new and may not be available forever. Click the link below to be among the first investors to get access to this timely, important new research!
The names of these top 3 dividend bets are all included. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.
Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of ASX Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.